Astrazeneca AZN
NYSE AZN
$163.70 +3.53 (+2.20%)
As of: Sep 14, 2026 · 3:06 PM EDT

Astrazeneca (AZN) Cash & Equivalents (QoQ) (2009 - 2026)

Analysis

Astrazeneca (AZN) Cash & Equivalents (QoQ) (2009 - 2026) Analysis & Trends

Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Asml Holding 618.78 Bn 602.80 Bn 5.90 Bn
2 Hsbc Holdings 362.62 Bn 362.62 Bn -
3 General Electric 329.79 Bn 320.45 Bn 6.95 Bn
4 Astrazeneca 253.78 Bn 248.49 Bn 12.86 Bn
5 Citigroup 228.38 Bn -2,073.93 Bn 24.75 Bn
6 Bhp 216.07 Bn 197.52 Bn -
7 Rio Tinto 203.71 Bn 199.33 Bn -
8 Diageo 197.09 Bn 195.06 Bn -
9 Unilever 139.31 Bn 132.28 Bn -
10 Hdfc Bank 117.84 Bn 80.69 Bn -
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 -35.28%
Mar 31, 2026 32.38%
Dec 31, 2025 -29.87%
Sep 30, 2025 15.37%
Jun 30, 2025 34.95%
Mar 31, 2025 -4.70%
Dec 31, 2024 14.40%
Sep 30, 2024 -30.64%
Jun 30, 2024 -11.80%
Mar 31, 2024 34.26%
Dec 31, 2023 19.89%
Sep 30, 2023 -14.00%
Jun 30, 2023 -9.11%
Mar 31, 2023 1.07%
Dec 31, 2022 38.31%
Sep 30, 2022 -7.45%
Jun 30, 2022 -16.40%
Mar 31, 2022 -8.96%
Dec 31, 2021 -10.44%
Sep 30, 2021 -54.60%